• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 7 of 100
Semaglutide medications Wegovy and Ozempic are pictured
Health
Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers
By Bloomberg, Madison Muller, Ike Swetlitz and Naomi KresgeFebruary 21, 2025
United States President Donald J. Trump speaks at the Friends of Ireland luncheon hosted by United States Speaker of the House of Representatives Paul Ryan, Republican of Wisconsin, at the United States Capitol March 15, 2018 in Washington, DC.
Finance
Weight-loss drug Zepbound helped drive Ireland to $76 billion in goods exports to the U.S. last year—a bittersweet reminder of the challenges ahead
By Ryan HoggFebruary 19, 2025
A woman holds a medicine bottle while reading instructions.
Health
Gen Z’s expensive drug habit: More want brand-name meds that are 79% more expensive
By Lindsey LeakeFebruary 14, 2025
Hens at a poultry farm
Health
Experts sound the alarm as Ohio farmworker’s bird flu sparks fear it’s the next pandemic
By Lindsey LeakeFebruary 13, 2025
A woman injects herself with medication.
Health
Ozempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’
By Lindsey LeakeFebruary 11, 2025
Cancer vaccination, conceptual illustration
Health
Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows
By Lindsey LeakeFebruary 7, 2025
A young woman undergoes a brain scan.
Health
Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drug
By Lindsey LeakeFebruary 6, 2025
AstraZeneca sees profits surge despite Chinese import tax allegations
Health
AstraZeneca sees profits surge despite Chinese import tax allegations
By AFPFebruary 6, 2025
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
Commentary
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
By Jeffrey Sonnenfeld and Steven TianFebruary 5, 2025
A middle-aged man picks up his medications at a pharmacy.
Health
Patients will pay more for prescription meds and face drug shortages amid Trump tariffs, pharma groups warn
By Lindsey LeakeFebruary 5, 2025
Novo Nordisk President and CEO Lars Fruergaard Jorgensen testifies before the Senate Health, Education, Labor, and Pensions Committee in the Dirksen Senate Office Building on Capitol Hill on September 24, 2024 in Washington, DC. The committee heard testimony from Jorgensen about the price of popular pharmaceuticals made by Novo Nordisk that help treat diabetes and obesity, including Wegovy and Ozempic.
Leadership
As U.S. firms scrap diversity targets, the CEO behind Ozempic and Wegovy took a pay cut for missing them
By Ryan HoggFebruary 5, 2025
Karsten Munk Knudsen, chief financial officer of Novo Nordisk A/S, at the company's headquarters in Bagsvaerd, Denmark, on Tuesday, Nov. 26, 2024.
Health
As growth slows, CFO says Novo Nordisk is prepping for the next generation of weight loss drugs
By Ryan HoggFebruary 5, 2025
GSK reports fall in profit over Zantac fallout—but boosts 2031 revenue target to £40 billion due to boom in cancer drug sales
Finance
GSK reports fall in profit over Zantac fallout—but boosts 2031 revenue target to £40 billion due to boom in cancer drug sales
By AFPFebruary 5, 2025
Albert Bourla, chief executive officer of Pfizer Inc., during a panel session at the World Economic Forum
Health
Pfizer CEO had dinner with RFK Jr.: ‘I’m cautiously optimistic’ in spite of his history with vaccines
By Hallie SteinerFebruary 4, 2025
Close-up of cast metal sign for the pharmaceutical company Merck
Health
Merck touts 20 new ‘blockbuster’ drugs in development with $50 billion potential
By Hallie SteinerFebruary 4, 2025
1...
  • 5
  • 6
  • 7
  • 8
  • 9
...100
Most Popular
Success
Jeff Bezos says a 3-day workweek and more single-income households are on the way thanks to AI: ‘It’s going to be difficult to hire people’placeholder alt text
By Preston ForeOctober 9, 2026
Success
Palantir’s billionaire CEO says only two kinds of people will succeed in the AI era: trade workers—‘or you’re neurodivergent’placeholder alt text
By Preston ForeOctober 10, 2026
Big Tech
Nvidia built a $5 trillion company while making employees pay for their own lunch—but they get far more lucrative perks like stock discountsplaceholder alt text
By Marco Quiroz-GutierrezOctober 10, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.